Moderna Surges on Cancer Vaccine; Estee Lauder Rallies on Earnings | Stock Movers
On this episode of Stock Movers: - Shares of Moderna (MRNA) surged by a record 101% - the stock’s biggest …
معلومات السوق الآنية عبر فئات الأصول
Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.
Over the last 30 days, AI sentiment for MRNA skewed bullish (3 of 6 scored calls).
أخبار منتقاة بالذكاء الاصطناعي تؤثر على سعر MRNA والمشاعر والاتجاه
On this episode of Stock Movers: - Shares of Moderna (MRNA) surged by a record 101% - the stock’s biggest …
Shares of Moderna and Merck soared on Wednesday morning after a study showed that a vaccine they produced had promising …
Merck and Moderna announced positive results from a large late-stage trial of their personalized mRNA cancer vaccine, which significantly reduced …
The vaccine candidate pairs an mRNA therapy with the cancer drug Keytruda.
On this episode of Stock Movers: - RocketLab (RKLB) shares are higher this morning after rising Friday, following earnings from …
Moderna’s mRNA-based flu vaccine, mFlusiva, is approved by the Food and Drug Administration for adults aged 50 and over.
تحليل متعدد المزودين بالذكاء الاصطناعي